Clinical trial NCT05498142 - References

Critical Illness — Predicting the Risk of Venous Thromboembolism in Critically Ill Patients

Citation(s)

•   Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ
  Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews. Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
•   Gaus H, Gülzow M, Meyer-Hofmann G
  [Late lesions following thorotrast use]. Klin Wochenschr. 1966 Jan 1;44(1):32-9. German.
•   Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KG
  Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010 Jul;63(7):721-7. doi: 10.1016/j.jclinepi.2009.12.008. Epub 2010 Mar 24.
•   Riley RD, Debray TPA, Collins GS, Archer L, Ensor J, van Smeden M, Snell KIE
  Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat Med. 2021 Aug 30;40(19):4230-4251. doi: 10.1002/sim.9025. Epub 2021 May 24.
•   Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M
  Calculating the sample size required for developing a clinical prediction model. BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441.
•   Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nuñez JJ, Zhang Y, Wiercioch W
  American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
•   Spyropoulos AC
  Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost. 2009 Jun;7(6):1041-2. doi: 10.1111/j.1538-7836.2009.03351.x.
•   Sullivan LM, Massaro JM, D'Agostino RB Sr
  Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004 May 30;23(10):1631-60. Review.
•   Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW
  A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016 Jun;74:167-76. doi: 10.1016/j.jclinepi.2015.12.005. Epub 2016 Jan 6.
•   Viarasilpa T, Panyavachiraporn N, Marashi SM, Van Harn M, Kowalski RG, Mayer SA
  Prediction of Symptomatic Venous Thromboembolism in Critically Ill Patients: The ICU-Venous Thromboembolism Score. Crit Care Med. 2020 Jun;48(6):e470-e479. doi: 10.1097/CCM.0000000000004306.
•   Vickers AJ, Elkin EB
  Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006 Nov-Dec;26(6):565-74.
•   Wetterslev M, Møller MH, Granholm A, Haase N, Hassager C, Lange T, Hästbacka J, Wilkman E, Myatra SN, Shen J, An Y, Siegemund M, Young PJ, Aslam TN, Szczeklik W, Aneman A, Arabi YM, Cronhjort M, Keus F, Perner A
  New-onset atrial fibrillation in the intensive care unit: Protocol for an international inception cohort study (AFIB-ICU). Acta Anaesthesiol Scand. 2021 Jul;65(6):846-851. doi: 10.1111/aas.13827. Epub 2021 Apr 23.

Predicting the Risk of Venous Thromboembolism in Critically Ill Patients: Validation of Pre-existing Risk Prediction Models and Development of a Prediction Model

Details for clinical trial NCT05498142